NeuroSense Therapeutics Ltd.
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has NeuroSense Therapeutics Ltd.'s balance sheet done over the years? Its assets were worth $3,176,000 last year, which is less than in the previous period. 159% of NeuroSense Therapeutics Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $5,050,000, which means an increase by 142% compared compared to last year.

Debt to Assets

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN): Debt to assets
2019 955000 37K 3.87%
2020 779000 120K 15.4%
2021 11431000 2.42M 21.21%
2022 7710000 2.09M 27.12%
2023 3176000 5.05M 159.01%

NRSN Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
2.64M3.54M11.06M699K895K
Short term investments
03.54M000
Net receivables
166K131K178K30K18K
Inventory
0-3.67M-178K-67-18
Other current assets
110K3.83M349K6718
Total current assets
2.91M7.38M11.41M729K913K
Non-current assets:
Property, Plant and Equipment
238K306K19K13K7K
Goodwill
00000
Intangible assets
00000
Long term investments
22K23K037K35K
Other non-current assets
00000
Total non-current assets
260K329K19K50K42K
Total assets
3.17M7.71M11.43M779K955K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
69K64K000
Total current liabilities
3.45M1.72M597K120K37K
Non-current liabilities:
Long term debt
73K147K1.82M00
Deferred tax
00000
Other non-current liabilities
1.51M218K000
Total non-current liabilities
1.59M365K1.82M00
Total liabilities
5.05M2.09M2.42M120K37K
Data sourceData sourceData source